Rocky Mountain spotted fever in the United States, 1997-2002

Annals of the New York Academy of Sciences

Volumn 1078, Issue , 2006, Pages 154-155

  Chapman, Alice S ^a,b   Murphy, Staci M ^a   Demma, Linda J ^a   Holman, Robert C ^a   Curns, Aaron T ^a   McQuiston, Jennifer H ^a   Krebs, John W ^a   Swerdlow, David L ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Epidemiology; Rocky Mountain spotted fever; Surveillance

Indexed keywords

AWARENESS; CONFERENCE PAPER; DISEASE CARRIER; HUMAN; MORTALITY; PHYSICIAN; RASH; ROCKY MOUNTAIN SPOTTED FEVER; STRESS; TICK; UNITED STATES;

IXODIDA;

EID: 33845697943     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1374.026     Document Type: Conference Paper

References (2)

1. TREADWELL, T.A., R.C. HOLMAN, M.J. CLARKE, et al. 2000. Rocky Mountain spotted fever in the United States, 1993-1996. Am. J. Trop. Med. Hyg. 6: 21-26.
2. HOLMAN, R.C., C.D. PADDOCK, A.T. CURNS, et al. 2001. Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy. J. Infect. Dis. 184: 1437-1444.